Simon MacKay

Active

MRC-DPFS Full Application 2023 - Targeting Inhibitory kappa B kinase alpha (IKKalpha): a new treatment paradigm for inflammatory-driven cancers

MacKay, S. (Principal Investigator) & Paul, A. (Co-investigator)

1/04/24 → 31/03/27

Project: Research

Finished

TargoPep: a cell selective delivery platform for therapeutic payloads (Follow on Fund)

Burley, G. (Principal Investigator), MacKay, S. (Co-investigator), Perrie, Y. (Co-investigator) & McWhinnie, F. (Research Co-investigator)

BBSRC (Biotech & Biological Sciences Research Council)

1/03/23 → 30/12/24

Project: Research

Development of a first-in-class IKKalpha inhibitor for the treatment of castrate resistant p

MacKay, S. (Principal Investigator), Halbert, G. (Co-investigator), Paul, A. (Co-investigator), Suckling, C. (Co-investigator) & Watson, D. (Co-investigator)

Prostate Cancer UK

1/10/20 → 31/12/24

Project: Research

CRUK evaluation of IKK inhibitors

MacKay, S. (Principal Investigator)

Cancer Research UK CRUK

1/11/18 → 31/12/18

Project: Research

David Begg / NSF Studentship | Webb, Cameron

Perrie, Y. (Principal Investigator), MacKay, S. (Co-investigator) & Webb, C. (Research Co-investigator)

EPSRC (Engineering and Physical Sciences Research Council)

1/10/18 → 16/05/22

Project: Research Studentship - Internally Allocated

Prevention of CXCL12 production in cells of the cardiovascular system by IKK alpha inhibition (BHF PhD Studentship)

Plevin, R. (Principal Investigator), Coats, P. (Co-investigator), MacKay, S. (Co-investigator) & Paul, A. (Co-investigator)

British Heart Foundation BHF

1/10/18 → 30/03/22

Project: Research - Studentship

Identification of pre-clinical SK1 inhibitors for the treatment of Pulmonary Hypertension

Pyne, N. (Principal Investigator), MacKay, S. (Co-investigator) & Pyne, S. (Co-investigator)

SULSA (University Administered)

26/10/13 → 25/10/14

Project: Research

First-in-class drugs for CRPC

MacKay, S. (Principal Investigator), Boyd, M. (Co-investigator), Paul, A. (Co-investigator), Plevin, R. (Co-investigator) & Suckling, C. (Co-investigator)

Prostate Cancer Charity

1/05/13 → 30/04/16

Project: Research

Neuroprotective compounds acting as antagonists at A2a receptors

MacKay, S. (Principal Investigator)

SULSA (University Administered)

20/02/12 → 9/07/12

Project: Research

SMSdrug.net: Alignment Of Synthesis, Medicinal Chemistry And Strucrural Genomics To Accelerate Uk Drug Discovery: Network SMS-Drug

Tomkinson, N. (Principal Investigator), C. Bagley, M. (Academic), Feilden, H. (Academic), Johnston, B. (Academic), Knapp, S. (Academic), MacKay, S. (Academic), Overington, J. (Academic) & Spencer, J. (Academic)

EPSRC (Engineering and Physical Sciences Research Council)

1/09/11 → 31/08/15

Project: Research

Ted Hupp Collaborative Input Into URUK Programme Grant

MacKay, S. (Principal Investigator)

Cancer Research UK CRUK

1/11/10 → 30/04/13

Project: Research - no external funding

DRUG DISCOVERY PORTAL COLLABORATION AGREEMENT

Harvey, A. (Principal Investigator) & MacKay, S. (Co-investigator)

University of Greenwich

29/05/08 → 28/05/13

Project: Research - no external funding

Drug discovery portal - SE marketing support

MacKay, S. (Principal Investigator)

Scottish Enterprise

1/05/08 → 31/07/09

Project: Research

LSBAS for Drug Discovery Portal

MacKay, S. (Principal Investigator)

SCOTTISH ENTERPRISE GLASGOW

1/05/08 → 30/04/09

Project: Research

A comprehensive multidisciplinary approach to target the inhibitory kappa B kinase pathway to discover novel therapies in prostate cancer

MacKay, S. (Principal Investigator), Gray, A. (Co-investigator), Harvey, A. (Co-investigator), Murphy, J. (Co-investigator), Paul, A. (Co-investigator) & Suckling, C. (Co-investigator)

Cancer Research UK CRUK

1/04/08 → 30/04/14

Project: Research